Astria Therapeutics, Inc (ATXS) insider trading
Every open-market stock purchase and sale by Astria Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Perceptive Advisors LLC (Director), $30M, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent ATXS insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jan 23, 2026 | Jill C. Milne (CEO) | Sold (not open market) | $4.9M |
| Jan 23, 2026 | Andrea Matthews (C-suite exec) | Sold (not open market) | $1.7M |
| Jan 23, 2026 | Christopher Morabito (C-suite exec) | Sold (not open market) | $1.7M |
| Jan 23, 2026 | Noah Clauser (CFO) | Sold (not open market) | $1.7M |
| Jan 23, 2026 | Benjamin Harshbarger (C-suite exec) | Sold (not open market) | $1.7M |
| Jan 23, 2026 | Andrew Komjathy (C-suite exec) | Sold (not open market) | $1.4M |
| Jan 23, 2026 | Jill C. Milne (CEO) | Sold (not open market) | $1.3M |
| Jan 23, 2026 | Benjamin Harshbarger (C-suite exec) | Sold (not open market) | $432K |
| Jan 23, 2026 | Benjamin Harshbarger (C-suite exec) | Sold (not open market) | $358K |
| Jan 23, 2026 | Noah Clauser (CFO) | Sold (not open market) | $358K |
| Jan 23, 2026 | Andrew Komjathy (C-suite exec) | Sold (not open market) | $358K |
| Jan 23, 2026 | Sunil Agarwal (Insider) | Sold (not open market) | $321K |
| Jan 23, 2026 | Christopher Morabito (C-suite exec) | Sold (not open market) | $310K |
| Jan 23, 2026 | Andrea Matthews (C-suite exec) | Sold (not open market) | $216K |
| Jan 23, 2026 | Andrea Matthews (C-suite exec) | Sold (not open market) | $214K |
| Jan 23, 2026 | Anthony Gregg Lapointe (Insider) | Sold (not open market) | $204K |
| Jan 23, 2026 | Michael D Kishbauch (Insider) | Sold (not open market) | $204K |
| Jan 23, 2026 | Hugh M Cole (Insider) | Sold (not open market) | $204K |
| Jan 23, 2026 | Joanne T. Beck (Insider) | Sold (not open market) | $204K |
| Jan 23, 2026 | Kenneth Bate (Insider) | Sold (not open market) | $204K |
| Jan 23, 2026 | Jonathan Violin (Insider) | Sold (not open market) | $173K |
| Jan 23, 2026 | Fred Callori (Insider) | Sold (not open market) | $173K |
| Jan 23, 2026 | Joanne T. Beck (Insider) | Sold (not open market) | $154K |
| Jan 23, 2026 | Sunil Agarwal (Insider) | Sold (not open market) | $154K |
| Jan 23, 2026 | Jonathan Violin (Insider) | Sold (not open market) | $154K |
Who's trading ATXS
- Jonathan Violin, Insider: other filings, last Jan 23, 2026
- Kenneth Bate, Insider: other filings, last Jan 23, 2026
- Joanne T. Beck, Insider: other filings, last Jan 23, 2026
- Fred Callori, Insider: other filings, last Jan 23, 2026
- Noah Clauser, CFO: other filings, last Jan 23, 2026
- Hugh M Cole, Insider: other filings, last Jan 23, 2026
- Benjamin Harshbarger, C-suite exec: other filings, last Jan 23, 2026
- Michael D Kishbauch, Insider: other filings, last Jan 23, 2026
- Andrew Komjathy, C-suite exec: other filings, last Jan 23, 2026
- Anthony Gregg Lapointe, Insider: other filings, last Jan 23, 2026
- Andrea Matthews, C-suite exec: other filings, last Jan 23, 2026
- Jill C. Milne, CEO: other filings, last Jan 23, 2026
- Christopher Morabito, C-suite exec: other filings, last Jan 23, 2026
- Sunil Agarwal, Director: other filings, last Jan 23, 2026
Get free alerts when an insider at Astria Therapeutics, Inc files a new trade →